Invention Grant
- Patent Title: Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
-
Application No.: US15421473Application Date: 2017-02-01
-
Publication No.: US10465003B2Publication Date: 2019-11-05
- Inventor: Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent William J. Simmons
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P3/10 ; A61P29/00 ; A61M5/00 ; A61M5/315 ; A61K39/00
Abstract:
The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
Public/Granted literature
- US20170247444A1 ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES Public/Granted day:2017-08-31
Information query
